| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Triamterene measurement |
Component |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Triamterene adverse reaction |
Causative agent (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Allergy to triamterene |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely triamterene 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Co-triamterzide 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Co-triamterzide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Triamterene and thiazide diuretic adverse reaction |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Product containing hydrochlorothiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Triamterene+thiazide diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Product containing chlortalidone and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzthiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Triamterene and loop diuretic adverse reaction |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Triamterene and loop diuretic allergy |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Allergy to triamterene and thiazide diuretic |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Triamterene+loop diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
|
| Product containing furosemide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Allergy to triamterene |
Causative agent (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Triamterene and loop diuretic allergy |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Allergy to triamterene and thiazide diuretic |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamterene 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamterene 50 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide 25 mg and triamterene 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Benzthiazide 25 mg and triamterene 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamterene 50 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamterene (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzthiazide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlortalidone and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide- and triamterene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Chlortalidone and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrochlorothiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Furosemide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing only furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Chlortalidone and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide 25 mg and triamterene 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
| Benzthiazide 25 mg and triamterene 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamterene (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]